$MBBC
Marathon Bancorp, Inc. /MD/ Stock $mbbc

$mbbc Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000155837023019040 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023 Q2
Revenue	$2.402M	$2.405M
YoY Change	6.99%	18.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$48.05K	$44.83K	$205.0K
YoY Change		-41.5%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$916.5K	$841.8K
YoY Change	64.96%	167.87%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$242.9K	$287.7K	$672.2K
YoY Change	-38.18%	-54.18%
Income Tax	-$29.20K	$201.5K	$178.3K
% Of Pretax Income	-12.02%	70.04%	26.53%
Net Earnings	$272.1K	$86.20K	$493.8K
YoY Change	-9.72%	-83.14%
Net Earnings / Revenue	11.33%	3.58%
Basic Earnings Per Share	$0.13	$0.04
Diluted Earnings Per Share	$0.13	$0.04	$0.24
COMMON SHARES
Basic Shares Outstanding	2.157M	2.043M	2.153M
Diluted Shares Outstanding	2.044M	2.046M

Balance Sheet

Concept	2023 Q4	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$8.122M	$6.980M	$11.78M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$3.974M	$3.704M	$2.128M
YoY Change	73.89%	56.95%	26.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$312.9K	$337.0K	$486.9K
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$234.1M	$235.6M	$238.8M
YoY Change	-1.1%	-0.07%	8.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt			$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$20.00M	$13.00M	$8.000M
YoY Change
Other Long-Term Liabilities	$2.911M	$2.560M	$2.245M
YoY Change
Total Long-Term Liabilities	$22.91M	$15.56M	$10.24M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$22.91M	$15.56M	$10.24M
Total Liabilities	$202.3M	$204.2M	$207.5M
YoY Change	-1.33%	-0.22%	9.63%
SHAREHOLDERS EQUITY
Retained Earnings	$26.07M	$25.80M	$25.58M
YoY Change	5.47%	7.78%	9.2%
Common Stock	$7.349M	$7.315M	$7.274M
YoY Change	-13.55%	-14.39%	-14.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.83M	$31.46M	$31.28M
YoY Change
Total Liabilities & Shareholders Equity	$234.1M	$235.6M	$238.8M
YoY Change	-1.1%	-0.07%	8.53%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	$272.1K	$86.20K	$493.8K
YoY Change	-9.72%	-83.14%
Depreciation, Depletion And Amortization	$48.05K	$44.83K	$205.0K
YoY Change		-41.5%
Cash From Operating Activities	$622.9K	$366.7K	$1.989M
YoY Change		-75.16%
INVESTING ACTIVITIES
Capital Expenditures	$345.6K	$1.648M	$65.36K
YoY Change		2571.65%
Acquisitions
YoY Change
Other Investing Activities	$3.125M	$132.5K	-$14.36M
YoY Change
Cash From Investing Activities	$2.779M	-$1.515M	-$14.42M
YoY Change		-73.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.261M	-3.646M	15.78M
YoY Change		-126.71%
NET CHANGE
Cash From Operating Activities	622.9K	366.7K	1.989M
Cash From Investing Activities	2.779M	-1.515M	-14.42M
Cash From Financing Activities	-2.261M	-3.646M	15.78M
Net Change In Cash	1.141M	-4.795M	3.347M
YoY Change		-150.62%
FREE CASH FLOW
Cash From Operating Activities	$622.9K	$366.7K	$1.989M
Capital Expenditures	$345.6K	$1.648M	$65.36K
Free Cash Flow	$277.3K	-$1.281M	$1.924M
YoY Change		-190.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001835385
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2157497
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2157497
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q3	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Other Comprehensive Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2023#OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	000-56269
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	MARATHON BANCORP, INC.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2191258
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 Scott Street
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Wausau
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	WI
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	54403
CY2023Q3	dei	City Area Code CityAreaCode	715
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	845-7331
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q3	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2157497
CY2023Q3	us-gaap	Cash And Due From Banks CashAndDueFromBanks	3258420
CY2023Q2	us-gaap	Cash And Due From Banks CashAndDueFromBanks	2272088
CY2023Q3	us-gaap	Federal Funds Sold FederalFundsSold	3722000
CY2023Q2	us-gaap	Federal Funds Sold FederalFundsSold	9503000
CY2023Q3	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	6980420
CY2023Q2	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	11775088
CY2023Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	3941269
CY2023Q2	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	3762139
CY2023Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	8625718
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	8921715
CY2023Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	388554
CY2023Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	378046
CY2023Q3	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss	510381
CY2023Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	516089
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	2025197
CY2023Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	2158590
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	197663038
CY2023Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	197713756
CY2023Q3	us-gaap	Interest Receivable InterestReceivable	534187
CY2023Q2	us-gaap	Interest Receivable InterestReceivable	612724
CY2023Q3	us-gaap	Foreclosed Assets ForeclosedAssets	2312240
CY2023Q2	us-gaap	Foreclosed Assets ForeclosedAssets	2312240
CY2023Q3	us-gaap	Investment Owned Restricted Cost InvestmentOwnedRestrictedCost	815842
CY2023Q2	us-gaap	Investment Owned Restricted Cost InvestmentOwnedRestrictedCost	770273
CY2023Q3	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	8784172
CY2023Q2	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	8724198
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3703974
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2128392
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	337033
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	486916
CY2023Q3	us-gaap	Other Assets OtherAssets	1417718
CY2023Q2	us-gaap	Other Assets OtherAssets	1055069
CY2023Q3	us-gaap	Assets Assets	235625992
CY2023Q2	us-gaap	Assets Assets	238778599
CY2023Q3	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	24455871
CY2023Q2	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	26180842
CY2023Q3	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	164152256
CY2023Q2	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	171073464
CY2023Q3	us-gaap	Deposits Deposits	188608127
CY2023Q2	us-gaap	Deposits Deposits	197254306
CY2023Q3	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	13000000
CY2023Q2	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	8000000
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	2560484
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	2244775
CY2023Q3	us-gaap	Liabilities Liabilities	204168611
CY2023Q2	us-gaap	Liabilities Liabilities	207499081
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2157497
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2157497
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	21141
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	21141
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7293997
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7252506
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	25796872
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	25577300
CY2023Q3	us-gaap	Unearned Esop Shares UnearnedESOPShares	777832
CY2023Q2	us-gaap	Unearned Esop Shares UnearnedESOPShares	786572
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-876797
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-784857
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	31457381
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31279518
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	235625992
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	238778599
CY2023Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	2180645
CY2022Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	1911400
CY2023Q3	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	57963
CY2022Q3	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	70217
CY2023Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	166529
CY2022Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	45526
CY2023Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	2405137
CY2022Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	2027143
CY2023Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	762801
CY2022Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	304400
CY2023Q3	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	79016
CY2022Q3	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	9862
CY2023Q3	us-gaap	Interest Expense InterestExpense	841817
CY2022Q3	us-gaap	Interest Expense InterestExpense	314262
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1563320
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1712881
CY2023Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	41000
CY2023Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	1522320
CY2022Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	1712881
CY2023Q3	mara	Service Charges On Deposit Accounts ServiceChargesOnDepositAccounts	31279
CY2022Q3	mara	Service Charges On Deposit Accounts ServiceChargesOnDepositAccounts	40866
CY2023Q3	mara	Mortgage Banking Income MortgageBankingIncome	130604
CY2022Q3	mara	Mortgage Banking Income MortgageBankingIncome	81590
CY2023Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	59974
CY2022Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	57026
CY2022Q3	mara	Gain On Proceeds From Life Insurance GainOnProceedsFromLifeInsurance	173268
CY2023Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	6382
CY2022Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	7454
CY2023Q3	us-gaap	Noninterest Income NoninterestIncome	228239
CY2022Q3	us-gaap	Noninterest Income NoninterestIncome	360204
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	772790
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	831867
CY2023Q3	us-gaap	Occupancy Net OccupancyNet	169822
CY2022Q3	us-gaap	Occupancy Net OccupancyNet	171521
CY2023Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	109644
CY2022Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	87050
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	170736
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	185067
CY2023Q3	us-gaap	Marketing Expense MarketingExpense	15189
CY2022Q3	us-gaap	Marketing Expense MarketingExpense	17806
CY2023Q3	us-gaap	Foreclosed Real Estate Expense ForeclosedRealEstateExpense	13620
CY2023Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	211082
CY2022Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	151960
CY2023Q3	us-gaap	Noninterest Expense NoninterestExpense	1462883
CY2022Q3	us-gaap	Noninterest Expense NoninterestExpense	1445271
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	287676
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	627814
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	201479
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	116661
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	86197
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	511153
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2043296
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2147781
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2046349
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2147781
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	86197
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	511153
CY2023Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	-118316
CY2022Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	-177671
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-24837
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-48400
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-93479
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-129271
CY2023Q3	us-gaap	Oci Debt Securities Available For Sale Transfer To Held To Maturity Adjustment From Aoci For Amortization Of Gain Loss After Tax OciDebtSecuritiesAvailableForSaleTransferToHeldToMaturityAdjustmentFromAociForAmortizationOfGainLossAfterTax	-1539
CY2022Q3	us-gaap	Oci Debt Securities Available For Sale Transfer To Held To Maturity Adjustment From Aoci For Amortization Of Gain Loss After Tax OciDebtSecuritiesAvailableForSaleTransferToHeldToMaturityAdjustmentFromAociForAmortizationOfGainLossAfterTax	-1461
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-91940
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-127810
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5743
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	383343
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31279518
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	86197
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-91940
CY2023Q3	mara	Employee Stock Ownership Plan Esop Amount Of Committed To Be Released Shares In Shares EmployeeStockOwnershipPlanEsopAmountOfCommittedToBeReleasedSharesInShares	874
CY2023Q3	mara	Employee Stock Ownership Plan Esop Amount Of Committed To Be Released Shares EmployeeStockOwnershipPlanEsopAmountOfCommittedToBeReleasedShares	10456
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39775
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	31457381
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	30742567
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	511153
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-127810
CY2022Q3	mara	Employee Stock Ownership Plan Esop Amount Of Committed To Be Released Shares In Shares EmployeeStockOwnershipPlanEsopAmountOfCommittedToBeReleasedSharesInShares	874
CY2022Q3	mara	Employee Stock Ownership Plan Esop Amount Of Committed To Be Released Shares EmployeeStockOwnershipPlanEsopAmountOfCommittedToBeReleasedShares	9614
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	34620
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	31170144
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	86197
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	511153
CY2023Q3	us-gaap	Depreciation Depreciation	44825
CY2022Q3	us-gaap	Depreciation Depreciation	50221
CY2023Q3	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	41000
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	39775
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	34620
CY2023Q3	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	10456
CY2022Q3	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	9614
CY2023Q3	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-24044
CY2022Q3	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-25855
CY2023Q3	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	11561
CY2022Q3	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	10182
CY2023Q3	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	65867
CY2022Q3	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	34295
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	139805
CY2022Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	80049
CY2022Q3	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	173268
CY2023Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	59974
CY2022Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	57026
CY2023Q3	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-78537
CY2022Q3	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-11966
CY2023Q3	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	2601000
CY2022Q3	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	871800
CY2023Q3	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	2666867
CY2022Q3	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	906095
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	649
CY2022Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-9403
CY2023Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	362649
CY2022Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	28388
CY2023Q3	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	335577
CY2022Q3	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1031253
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	366681
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1476464
CY2023Q3	mara	Net Change Interest Bearing Deposits In Other Financial Institutions NetChangeInterestBearingDepositsInOtherFinancialInstitutions	179130
CY2022Q3	mara	Net Change Interest Bearing Deposits In Other Financial Institutions NetChangeInterestBearingDepositsInOtherFinancialInstitutions	-1638560
CY2022Q3	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	641757
CY2023Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	153377
CY2022Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	324406
CY2023Q3	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	7509
CY2022Q3	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	7437
CY2023Q3	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	45569
CY2022Q3	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	447273
CY2023Q3	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-196279
CY2022Q3	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	7759425
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1647636
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61671
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1515170
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5656209
CY2023Q3	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-8646179
CY2022Q3	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-347733
CY2023Q3	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	5000000
CY2022Q3	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	14000000
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3646179
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13652267
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4794668
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9472522
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11775088
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8428041
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6980420
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17900563
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	771411
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	318141
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	191000
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	35000
CY2022Q3	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	698837
CY2021Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1003274
CY2021Q2	us-gaap	Share Price SharePrice	10.00
CY2021Q2	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.450
CY2021Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	10000000.0
CY2021Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1400000
CY2021Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	8500000
CY2023Q3	mara	Number Of Business Facilities NumberOfBusinessFacilities	4
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	86197
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	511153
CY2023Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2121516
CY2022Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2229497
CY2023Q3	us-gaap	Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased	78220
CY2022Q3	us-gaap	Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased	81716
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2043296
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2147781
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3053
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2046349
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2147781
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2023Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	8625718
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	8921715
CY2023Q3	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss	510381
CY2023Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	516089
CY2023Q3	mara	Debt Securities Available For Sale And Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss	9136099
CY2023Q2	us-gaap	Debt Securities Available For Sale And Held To Maturity DebtSecuritiesAvailableForSaleAndHeldToMaturity	9437804
CY2023Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	9761061
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	23706
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1159049
CY2023Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	8625718
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	9938742
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	23628
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1040655
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	8921715
CY2023Q3	us-gaap	Debt Securities Available For Sale Restricted DebtSecuritiesAvailableForSaleRestricted	355000
CY2023Q2	us-gaap	Debt Securities Available For Sale Restricted DebtSecuritiesAvailableForSaleRestricted	415000
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	502356
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	496420
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2851425
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2782002
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	4629786
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	3673420
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	7983567
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	6951842
CY2023Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	9761061
CY2023Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	8625718
CY2023Q3	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss	510381
CY2023Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	388554
CY2022Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2023Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	6197
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	343456
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1152852
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	7938550
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1159049
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	8282006
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	109618
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	1287089
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	931037
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	7391645
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1040655
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	8678734
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	9
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	57
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	15
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	52
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess	199756000
CY2023Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	199936000
CY2023Q3	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	-68000
CY2023Q2	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	63000
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Current FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent	2025000
CY2023Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	2159000
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent	197663000
CY2023Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	197714000
CY2023Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	2159000
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	41000
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	2025000
CY2022Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	2195050
CY2022Q3	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	-136753
CY2022Q3	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	572
CY2022Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	2058869
CY2022Q3	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	2058869
CY2022Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	2058869
CY2022Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	156056
CY2022Q3	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	195387590
CY2022Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	195543646
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	2158590
CY2023Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	2158590
CY2023Q2	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	117103
CY2023Q2	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	199818743
CY2023Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	199935846
CY2023Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	41000
CY2022Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	5421000
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	31597000
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	64970000
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	54492000
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	16696000
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	25107000
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	1473000
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	199756000
CY2023Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2023	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2023Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	117103
CY2023Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	117103
CY2023	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	123307
CY2023	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	6967
CY2023Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2022Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2023Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	564753
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	591982
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	558602
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	585182
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M23D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y10M17D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0325
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0324
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	31929
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	31929
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	9570
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	9750
CY2023Q3	us-gaap	Lease Cost LeaseCost	41499
CY2023	us-gaap	Lease Cost LeaseCost	41679
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	31281
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	30999
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	92688
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	104464
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	103720
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	94450
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	43200
CY2023Q3	mara	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	187200
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	625722
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	67120
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	558602
CY2023Q3	mara	Brokered Deposits BrokeredDeposits	17700000
CY2023Q2	mara	Brokered Deposits BrokeredDeposits	22200000
CY2023Q3	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	24455871
CY2023Q3	mara	Noninterest Bearing Deposit Liabilities Percent NoninterestBearingDepositLiabilitiesPercent	0.1297
CY2023Q2	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	26180842
CY2023Q2	mara	Noninterest Bearing Deposit Liabilities Percent NoninterestBearingDepositLiabilitiesPercent	0.1327
CY2023Q3	us-gaap	Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW	41062612
CY2023Q3	mara	Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now Percent DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNowPercent	0.2177
CY2023Q2	us-gaap	Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW	44664015
CY2023Q2	mara	Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now Percent DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNowPercent	0.2264
CY2023Q3	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	40441220
CY2023Q3	mara	Deposits Savings Deposits Percent DepositsSavingsDepositsPercent	0.2144
CY2023Q2	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	42554858
CY2023Q2	mara	Deposits Savings Deposits Percent DepositsSavingsDepositsPercent	0.2157
CY2023Q3	mara	Deposits Certificates Of Deposits DepositsCertificatesOfDeposits	82648424
CY2023Q3	mara	Deposits Certificates Of Deposits Percent DepositsCertificatesOfDepositsPercent	0.4382
CY2023Q2	mara	Deposits Certificates Of Deposits DepositsCertificatesOfDeposits	83854591
CY2023Q2	mara	Deposits Certificates Of Deposits Percent DepositsCertificatesOfDepositsPercent	0.4251
CY2023Q3	us-gaap	Deposits Deposits	188608127
CY2023Q3	mara	Deposits Percent DepositsPercent	1.0000
CY2023Q2	us-gaap	Deposits Deposits	197254306
CY2023Q2	mara	Deposits Percent DepositsPercent	1.0000
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	201000
CY2023Q3	mara	Increase In Income Tax Expense Over Prior Year Amount IncreaseInIncomeTaxExpenseOverPriorYearAmount	84000
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117000
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.700
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.186
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2023Q3	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-112000
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	60412
CY2022Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	131841
CY2023Q3	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-112058
CY2023Q3	mara	Effective Income Tax Rate Reconciliation Earnings On Bank Owned Life Insurance Amount EffectiveIncomeTaxRateReconciliationEarningsOnBankOwnedLifeInsuranceAmount	12594
CY2022Q3	mara	Effective Income Tax Rate Reconciliation Earnings On Bank Owned Life Insurance Amount EffectiveIncomeTaxRateReconciliationEarningsOnBankOwnedLifeInsuranceAmount	48505
CY2022Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	28108
CY2023Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	41603
CY2022Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	5217
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	201479
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	116661
CY2023Q3	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	29463000
CY2023Q3	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.1236
CY2023Q3	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	19070000
CY2023Q3	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.080
CY2023Q3	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	21454000
CY2023Q3	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.090
CY2023Q2	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	29030000
CY2023Q2	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.1202
CY2023Q2	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	19321000
CY2023Q2	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.080
CY2023Q2	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	21736000
CY2023Q2	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.090
CY2023Q3	mara	Net Worth Of Entity NetWorthOfEntity	28914828
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Current FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent	2025197
CY2023Q3	mara	Net Worth Of Entity Percent Of Total Assets NetWorthOfEntityPercentOfTotalAssets	0.1219
CY2023Q2	mara	Net Worth Of Entity NetWorthOfEntity	28246139
CY2023Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	2158590
CY2023Q2	mara	Net Worth Of Entity Percent Of Total Assets NetWorthOfEntityPercentOfTotalAssets	0.1267
CY2023Q3	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.15
CY2023Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	873970
CY2023Q3	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	87397
CY2023Q3	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	10.00
CY2023Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0325
CY2023Q3	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	10456
CY2023Q3	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	874
CY2022Q3	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	9614
CY2022Q3	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	874
CY2023Q3	us-gaap	Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares	77783
CY2023Q3	mara	Employee Stock Ownership Plan Esop Value Of Shares Committed To Be Released EmployeeStockOwnershipPlanEsopValueOfSharesCommittedToBeReleased	661156
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P3Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	104877
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.31
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M29D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	104877
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.31
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y29D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	18353
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.92
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y10M2D
CY2023Q3	mara	Number Of Investment Securities Measured At Fair Value On Recurring Basis Using Significant Unobservable Inputs NumberOfInvestmentSecuritiesMeasuredAtFairValueOnRecurringBasisUsingSignificantUnobservableInputs	1
CY2023Q2	mara	Number Of Investment Securities Measured At Fair Value On Recurring Basis Using Significant Unobservable Inputs NumberOfInvestmentSecuritiesMeasuredAtFairValueOnRecurringBasisUsingSignificantUnobservableInputs	1
CY2023Q3	mara	Significant Unobservable Input SignificantUnobservableInput	The Level 3 valuation is based on the 5/30 swap curve
CY2023Q3	mara	Significant Unobservable Input Float SignificantUnobservableInputFloat	0.01
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1580000
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1900000
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-120000
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-60000
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1460000
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1840000

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001558370-23-019040-index-headers.html	Edgar Link	pending
0001558370-23-019040-index.html	Edgar Link	pending
0001558370-23-019040.txt	Edgar Link	pending
0001558370-23-019040-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mara-20230930.xsd	Edgar Link	pending
mara-20230930x10q.htm	Edgar Link	pending
mara-20230930xex31d1.htm	Edgar Link	pending
mara-20230930xex31d2.htm	Edgar Link	pending
mara-20230930xex32d1.htm	Edgar Link	pending
mara-20230930xex32d2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
mara-20230930_cal.xml	Edgar Link	unprocessable
mara-20230930_def.xml	Edgar Link	unprocessable
mara-20230930_lab.xml	Edgar Link	unprocessable
mara-20230930_pre.xml	Edgar Link	unprocessable
mara-20230930x10q_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MBBC
Marathon Bancorp, Inc. /MD/ Stock $mbbc

2023 Q4 Form 10-Q Financial Statement

#000155837023019040 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MBBC Marathon Bancorp, Inc. /MD/ Stock $mbbc

2023 Q4 Form 10-Q Financial Statement

#000155837023019040 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MBBC
Marathon Bancorp, Inc. /MD/ Stock $mbbc